je.st

Home › committee meeting

Tag: committee meeting

Merck Statement on FDA Advisory Committee Meeting for Suvorexant

2013-05-23 00:28:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration (FDA) about suvorexant, Mercks investigational medicine to treat insomnia. Language: English Contact HTML: MerckMedia:Pam Eisele, 908-423-5042orTracy Ogden, 267-305-2301orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: statement meeting committee advisory

West Quadrant Plan Stakeholder Advisory Committee Meeting #4 Packet

2013-05-13 19:22:02| PortlandOnline

Materials for the fourth meeting of the Stakeholder Advisory Committee on May 20, 2013. Topics will include South Downtown, Downtown, the West End and Old Town/Chinatown. PDF Document, 3,183kbCategory: Stakeholder Advisory Committee

Tags: plan west meeting committee

West Quadrant Plan Stakeholder Advisory Committee Meeting #2 Approved Minutes

2013-05-13 18:03:25| PortlandOnline

Approved summary of the second meeting held on April 1, 2013. The committee discussed transportation, green systems, parks, open space and the Willamette River. PDF Document, 131kbCategory: Stakeholder Advisory Committee

Tags: plan west minutes meeting